Impact of genetic polymorphisms on heart failure prognosis.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Archives des maladies du coeur et des vaisseaux

• Publication date

  2003-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 12722550
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rules and guidelines for mouse gene, allele, and mutation nomenclature: a condensed version.

  2002cited by this paper
• The Myocardium-protective Gly-49 Variant of the β1-Adrenergic Receptor Exhibits Constitutive Activity and Increased Desensitization and Down-regulation*

  2002cited by this paper
• An aldosterone synthase gene variant is associated with improvement in left ventricular ejection fraction in dilated cardiomyopathy.

  2002cited by this paper
• Modifier genes for hypertrophic cardiomyopathy.

  2002cited by this paper
• Susceptibility-conferring polymorphic genotypes in cardiovascular multifactorial syndromes.

  2002cited by this paper
• Suppressive effect of the Gly389 allele of the beta1-adrenergic receptor gene on the occurrence of ventricular tachycardia in dilated cardiomyopathy.

  2002cited by this paper
• Seven-transmembrane-spanning receptors and heart function

  2002cited by this paper
• Microtubule-associated protein 1A is a modifier of tubby hearing (moth1)

  2002cited by this paper
• Amino Acid 49 Polymorphisms of the Human &bgr; 1 -Adrenergic Receptor Affect Agonist-Promoted Trafficking

  2002cited by this paper
• Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure.

  2002cited by this paper
• Genetic Modifier Loci Affecting Survival and Cardiac Function in Murine Dilated Cardiomyopathy

  2002cited by this paper
• MALDI-TOF mass spectrometry-based SNP genotyping.

  2002cited by this paper
• Blunted Cardiac Responses to Receptor Activation in Subjects With Thr164Ile &bgr;2-Adrenoceptors

  2001cited by this paper
• Functional Alterations of the Nppa Promoter Are Linked to Cardiac Ventricular Hypertrophy in WKY/WKHA Rat Crosses

  2001cited by this paper
• Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure.

  2001cited by this paper
• A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy.

  2001cited by this paper
• Finding the molecular basis of quatitative traits: successes and pitfalls

  2001cited by this paper
• Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy.

  2001cited by this paper
• Pharmacogenetic Interactions Between &bgr;-Blocker Therapy and the Angiotensin-Converting Enzyme Deletion Polymorphism in Patients With Congestive Heart Failure

  2001cited by this paper
• Are we ready for pharmacogenomics in heart failure?

  2001cited by this paper
• Cardiovascular genomics: estimating the total number of genes expressed in the human cardiovascular system.

  2001cited by this paper
• Aspects of gene polymorphisms in cardiovascular disease: the renin‐angiotensin system

  2001cited by this paper
• A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy.

  2001cited by this paper
• In Vivo Ventricular Gene Delivery of a &bgr;-Adrenergic Receptor Kinase Inhibitor to the Failing Heart Reverses Cardiac Dysfunction

  2001cited by this paper
• Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure.

  2000cited by this paper
• A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease.

  2000cited by this paper
• Analysing complex genetic traits with chromosome substitution strains

  2000cited by this paper
• Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart : prospects for molecular ventricular assistance.

  2000cited by this paper
• Evidence of Improving Prognosis in Heart Failure: Trends in Case Fatality in 66 547 Patients Hospitalized Between 1986 and 1995

  2000cited by this paper
• A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure.

  2000cited by this paper
• Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.

  2000cited by this paper
• The roads from phenotypic variation to gene discovery: mutagenesis versus QTLs

  2000cited by this paper
• A Gain-of-function Polymorphism in a G-protein Coupling Domain of the Human β1-Adrenergic Receptor*

  1999cited by this paper
• Angiotensin‐II type 1 receptor gene polymorphism and long‐term survival in patients with idiopathic congestive heart failure

  1999cited by this paper
• Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure.

  1999cited by this paper
• Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group.

  1999cited by this paper
• Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene. CARDIGENE group.

  1999cited by this paper
• Sequence diversity in 36 candidate genes for cardiovascular disorders.

  1999cited by this paper
• Does angiotensin-converting enzyme polymorphism influence the clinical manifestation and progression of heart failure in patients with dilated cardiomyopathy?

  1999cited by this paper
• Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function.

  1998cited by this paper
• Genetic mapping of the mouse genome.

  1998cited by this paper
• Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. VEST Investigators for TNF Genotype Analysis. Vesnarinone Survival Trial.

  1998cited by this paper
• The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure.

  1998cited by this paper
• Positional cloning and gene identification.

  1998cited by this paper
• Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor

  1996cited by this paper
• The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure.

  1996cited by this paper
• Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice.

  1996cited by this paper
• A comprehensive genetic map of the mouse genome

  1996cited by this paper
• Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy.

  1995cited by this paper
• A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor.

  1993cited by this paper
• Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy.

  1993cited by this paper
• Detecting marker-QTL linkage and estimating QTL gene effect and map location using a saturated genetic map.

  1993cited by this paper
• An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

  1990cited by this paper
• Mapping mendelian factors underlying quantitative traits using RFLP linkage maps.

  1989cited by this paper
• Longevity and gross pathology at death in 22 inbred mouse strains.

  1966cited by this paper

• ventricular hypertrophy background-dependent development of concentric left and C57BL/6J mice: temporal- and Cardiac response to pressure overload in 129S1/SvImJ

  2016cites this paper
• [Pharmacogenomic control of angiotensin converting enzyme gene I/D polymorphism predominant risk factor of development of chronic heart failure and target of enalapril treatment].

  2013cites this paper
• [Impact of Gly389Arg beta1-adrenoceptor polymorphism on the risk of chronic heart failure, the nature of its course, and on the efficiency of its treatment with carvedilol].

  2010cites this paper
• Tnni3k Modifies Disease Progression in Murine Models of Cardiomyopathy

  2009cites this paper
• Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal- and background-dependent development of concentric left ventricular hypertrophy.

  2007cites this paper
• New Markers of Sudden Cardiac Death: Genetic Variables

  2006cites this paper
• Having a heart attack? Avoid the "HETE"!

  2006cites this paper
• Mortality in patients with hypertension on angiotensin-I converting enzyme (ACE)-inhibitor treatment is influenced by the ACE insertion/deletion polymorphism

  2005cites this paper
• The genetic basis for cardiac remodeling.

  2005cites this paper
• Drug-Induced Torsade de Pointes. Role of Genetic Factors

  2004cites this paper
• Genetic predisposition to heart failure.

  2004cites this paper
• Integration of myofibrils in the developing heart and challenges on the intercalated disc stability

  2004cites this paper
• Risk Stratification and Management of Sudden Cardiac Death:

  2003cites this paper